-
Symbol
-
GDTC on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Ordinary Shares, no par value per share
-
Latest Disclosed Ownership
-
880K shares
-
Security Ownership
-
7.62%
28 Consultants Ltd ownership in CytoMed Therapeutics Ltd Ordinary Shares, no par value per share (GDTC)
2025-03-04 - 28 Consultants Ltd has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 880K shares of CytoMed Therapeutics Ltd Ordinary Shares, no par value per share (GDTC).
This represents 7.62% percent ownership of the company.